Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 11, Pages 1820
Publisher
MDPI AG
Online
2019-11-20
DOI
10.3390/cancers11111820
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
- (2019) Vicky Makker et al. LANCET ONCOLOGY
- Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
- (2019) Gaia Giannone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth
- (2019) Yongtao Gao et al. International Journal of Nanomedicine
- BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1
- (2019) Jing Hu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
- (2019) Sarah J. Kitson et al. Cancers
- Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications
- (2019) Monica Marzagalli et al. SEMINARS IN CANCER BIOLOGY
- T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
- (2019) Dong Yang et al. Journal for ImmunoTherapy of Cancer
- Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
- (2018) Stephanie M de Boer et al. LANCET ONCOLOGY
- Inhibition of BMI1, a therapeutic approach in endometrial cancer.
- (2018) Megan Buechel et al. MOLECULAR CANCER THERAPEUTICS
- Signature program: a platform of basket trials
- (2018) Eric D. Slosberg et al. Oncotarget
- The Story of Imatinib in GIST - a Journey through the Development of a Targeted Therapy
- (2018) Peter Reichardt Oncology Research and Treatment
- Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells
- (2018) Miseon Kim et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- 71OPhase I extension study of ETC-159 an oral PORCN inhibitor administered with bone protective treatment, in patients with advanced solid tumours
- (2018) D Tan et al. ANNALS OF ONCOLOGY
- Endometrial Stem Cell Markers: Current Concepts and Unresolved Questions
- (2018) Nicola Tempest et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Endometrial Cancer Spheres Show Cancer Stem Cells Phenotype and Preference for Oxidative Metabolism
- (2018) Maria João Carvalho et al. PATHOLOGY & ONCOLOGY RESEARCH
- Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma
- (2018) Huan Lu et al. EBioMedicine
- Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma
- (2018) Yuta Tabuchi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Effects of metformin on endometrial cancer: Systematic review and meta-analysis
- (2017) Cinthia G. Meireles et al. GYNECOLOGIC ONCOLOGY
- Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor–Based Immunotherapy and Chemotherapy
- (2017) Rüdiger Klapdor et al. HUMAN GENE THERAPY
- Cancer stem cells as targets for immunotherapy
- (2017) Amy S. Codd et al. IMMUNOLOGY
- Autophagy plays an important role in stemness mediation and the novel dual function of EIG121 in both autophagy and stemness regulation of endometrial carcinoma JEC cells
- (2017) Xiaomin Ran et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
- (2017) Caner Saygin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- EMP2 is a novel therapeutic target for endometrial cancer stem cells
- (2017) M H Kiyohara et al. ONCOGENE
- Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma
- (2017) Ji Y. Park et al. PATHOLOGY & ONCOLOGY RESEARCH
- Overexpression of microRNA-194 suppresses the epithelial–mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells
- (2017) Baolan Gong et al. TUMOR BIOLOGY
- Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity
- (2017) Gloria Mittica et al. Oncotarget
- MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer
- (2017) Zhen Wang et al. Oncotarget
- Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
- (2017) Wei Xia Ang et al. Oncotarget
- Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment
- (2017) Yelei Guo et al. Protein & Cell
- 5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells
- (2017) Xueyang Guo et al. Scientific Reports
- Endometrial cancer: Not your grandmother's cancer
- (2016) Jessica N. McAlpine et al. CANCER
- Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells
- (2016) Chao Shang et al. CANCER BIOLOGY & THERAPY
- Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
- (2016) Piera Gargiulo et al. CANCER TREATMENT REVIEWS
- The Wnt signaling pathway in cancer
- (2016) Yann Duchartre et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer
- (2016) Michael S. Guy et al. GYNECOLOGIC ONCOLOGY
- Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer
- (2016) Samah S. Elbasateeny et al. PATHOLOGY RESEARCH AND PRACTICE
- Aldehyde dehydrogenase 1A1 in stem cells and cancer
- (2016) Hiroyuki Tomita et al. Oncotarget
- Epigenetics in Cancer: A Hematological Perspective
- (2016) Maximilian Stahl et al. PLoS Genetics
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
- (2015) N. Colombo et al. ANNALS OF ONCOLOGY
- Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
- (2015) Zhenling Deng et al. BMC IMMUNOLOGY
- Clinical translation for endometrial cancer stem cells hypothesis
- (2015) Maria João Carvalho et al. CANCER AND METASTASIS REVIEWS
- IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
- (2015) M. van der Zee et al. CANCER RESEARCH
- A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
- (2015) E. G. Chiorean et al. CLINICAL CANCER RESEARCH
- Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
- (2015) Brian M. Slomovitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- A Big Bang model of human colorectal tumor growth
- (2015) Andrea Sottoriva et al. NATURE GENETICS
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition
- (2015) B Madan et al. ONCOGENE
- Endometrial Cancer Stem Cell as a Potential Therapeutic Target
- (2015) Satoru Kyo et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Cancer stem cell targeted therapy: progress amid controversies
- (2015) Tao Wang et al. Oncotarget
- Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
- (2015) Xuekai Zhu et al. Oncotarget
- The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
- (2014) Alessandro Allegra et al. CANCER INVESTIGATION
- A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
- (2014) J. Rodon et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in Cancer
- (2014) R. A. Previs et al. CLINICAL CANCER RESEARCH
- MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins
- (2014) Yongtao Gao et al. FEBS LETTERS
- Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer
- (2014) Daliah Tsoref et al. GYNECOLOGIC ONCOLOGY
- SPARC was overexpressed in human endometrial cancer stem-like cells and promoted migration activity
- (2014) Nurismangul Yusuf et al. GYNECOLOGIC ONCOLOGY
- Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study
- (2014) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
- (2014) Peixin Dong et al. Journal of Translational Medicine
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
- (2013) N Colombo et al. BRITISH JOURNAL OF CANCER
- Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO
- (2013) I Ray-Coquard et al. BRITISH JOURNAL OF CANCER
- Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells
- (2013) Xiuzhi Zhang et al. CANCER LETTERS
- The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells
- (2013) Soshi Kusunoki et al. GYNECOLOGIC ONCOLOGY
- Epithelial-to-mesenchymal transition and stem cells in endometrial cancer
- (2013) Cristina Mirantes et al. HUMAN PATHOLOGY
- Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer
- (2013) MITSUHIRO NAKAMURA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- aSIRTing Control over Cancer Stem Cells
- (2012) Takahiro Ito et al. CANCER CELL
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Understanding cancer stem cell heterogeneity and plasticity
- (2012) Dean G Tang CELL RESEARCH
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer
- (2012) XIAOYAN QIN et al. Oncology Letters
- Stem cells in endometrium and endometrial cancer: Accumulating evidence and unresolved questions
- (2011) Satoru Kyo et al. CANCER LETTERS
- Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications
- (2011) Nur Rahadiani et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Expression of the Stem Cell Marker, Nanog, in Human Endometrial Adenocarcinoma
- (2011) Xi Zhou et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
- (2011) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Sodium Butyrate Inhibits the Self-Renewal Capacity of Endometrial Tumor Side-Population Cells by Inducing a DNA Damage Response
- (2011) K. Kato et al. MOLECULAR CANCER THERAPEUTICS
- Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer
- (2010) Mitsuhiro Nakamura et al. HUMAN PATHOLOGY
- The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosisviaNotch-1 and p21WAF1/CIP1
- (2010) Martin Götte et al. INTERNATIONAL JOURNAL OF CANCER
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
- (2010) RA Nout et al. LANCET
- A cancer stem cell origin for human endometrial carcinoma?
- (2010) Sonya A Hubbard et al. REPRODUCTION
- Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
- (2010) Anne M Friel et al. Reproductive Biology and Endocrinology
- Wnt signaling in stem and cancer stem cells
- (2010) Peter Wend et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Endometrial Cancer Side-Population Cells Show Prominent Migration and Have a Potential to Differentiate into the Mesenchymal Cell Lineage
- (2009) Kiyoko Kato et al. AMERICAN JOURNAL OF PATHOLOGY
- Modified Radical Hysterectomy Versus Extrafascial Hysterectomy in the Treatment of Stage I Endometrial Cancer: Results From the ILIADE Randomized Study
- (2009) Mauro Signorelli et al. ANNALS OF SURGICAL ONCOLOGY
- Differentiation therapy of leukemia: 3 decades of development
- (2009) D. Nowak et al. BLOOD
- CD133 antigen expression in ovarian cancer
- (2009) Gabriella Ferrandina et al. BMC CANCER
- Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop
- (2009) V. Levina et al. CANCER RESEARCH
- Evidence for Cancer Stem Cells in Human Endometrial Carcinoma
- (2009) S. A. Hubbard et al. CANCER RESEARCH
- Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors
- (2009) S. Rutella et al. CLINICAL CANCER RESEARCH
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- BRCA1 regulates human mammary stem/progenitor cell fate
- (2008) S. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now